Overview of the global blood coagulation analyzer market
Technavio’s market research analyst predicts that the global blood coagulation analyzer market will grow at a CAGR of more than 8% by 2020. Blood coagulation analyzers are used to estimate the composition of blood after blood tests. The coagulation analyzers available these days are fully automated with several advanced features to perform various functions such as primary tube sampling, cap piercing, automatic rerun, and dilution. They can perform sophisticated coagulation, chromogenic, and immunologic assays by using a smaller sample and reagent volume of the blood. Factors such as portability, accuracy, connectivity, timely results, and ease-of-use have increased the usage of these devices and have created ample opportunities for the vendors to come up with more effective and efficient solutions over the next four years.
An interesting trend gaining traction in the market is the growing use of anticoagulant therapy. Anticoagulant therapy is used for the treatment of clotting disorders occurring due to abnormal blood clots. It is used for treating atrial fibrillation, artificial heart valve, DVT, PE, stroke, and heart attack. Several governing bodies, including Anticoagulation Europe and Anticoagulation Self-monitoring Alliance, have taken initiatives to create awareness of the ill-effects of anticoagulant therapy. This increase in the awareness will increase the demand for coagulation testing, which in turn will propel the market in the coming years.
Segmentation by product type and analysis of the blood coagulation analyzer market
The instruments segment will continue its dominance in the market during the forecast period and is expected to account for around 59% of the total market share by 2020. The segment’s growth can be directly related to the increase in the number of laboratories worldwide. Technological advances such as dual and four channel systems, which are capable of simultaneously carrying out APTT, PT, FIB, and TT are expected to boost the growth of this segment over the next four years.
Geographical segmentation and analysis of the blood coagulation analyzer market
During 2015, the Americas dominated the market and occupied around 53% of the total market share. The primary reason for this region’s growth is the recent increase in the awareness of blood-related diseases among people, which will result in people taking up blood tests as a precautionary measure. Factors such as increased prevalence of CVDs that involves blood tests will augment the usage of coagulation analyzers in the region.
Competitive landscape and key vendors
The market is characterized by the presence of many diversified international and regional vendors. The key vendors dominate the market and distinguish themselves from the local players on the basis of quality, pricing, market reach, and financial resources. Competition in this market will intensify during the forecast period due to an increase in the number of laboratories worldwide and rapid technological advances related to the design, type, and method of coagulation analyzers. Several players are shifting to APAC owing to the presence of a huge patient population in the region and subsequent growth opportunities.
Key vendors in the market include -
- Abbott Diagnostics
- Danaher
- Roche Diagnostics
- Siemens Healthcare
- Sysmex
Other prominent vendors in the blood coagulation analyzer market include Accriva Diagnostics, Alere, A&T Corporation, Analyticon Biotechnologies, Cepheid, Corgenix, Diagnostica Stago, Helena Point of Care, Instrumentation Laboratory, LABiTec- LAbor BioMedical Technologies, Nihon Kohden, Randox Laboratories, Sekisui Medical, Sienco, Sinduri Biotec, Tcoag, and Thermo Fisher Scientific.
Key questions answered in the report include
- What will the market size and the growth rate be in 2020?
- What are the key factors driving the global blood coagulation analyzer market?
- What are the key market trends impacting the growth of the global blood coagulation analyzer market?
- What are the challenges to market growth?
- Who are the key vendors in the global blood coagulation analyzer market?
- What are the market opportunities and threats faced by the vendors in the global blood coagulation analyzer market?
- Trending factors influencing the market shares of the Americas, APAC, and EMEA.
- What are the key outcomes of the five forces analysis of the global blood coagulation analyzer market?
Technavio also offers customization on reports based on specific client requirement.
Related reports:
Table of Content
PART 01: Executive summary
PART 02: Scope of the report
- Market overview
- Top-vendor offerings
PART 03: Market research methodology
- Research methodology
- Economic indicators
PART 04: Introduction
PART 05: Market landscape
- Market overview
- Market size and forecast
- Five forces analysis
PART 06: Market segmentation by product type
- Market overview
- Global blood coagulation instrument market
- Global blood coagulation consumables market
PART 07: Blood coagulation instrument market
PART 08: Segmentation by method of testing
PART 09: Geographical segmentation
- Market overview
- Blood coagulation analyzer market in Americas
- Blood coagulation analyzer market in EMEA
- Blood coagulation analyzer market in APAC
PART 10: Market drivers
PART 11: Impact of drivers
PART 12: Market challenges
PART 13: Impact of drivers and challenges
PART 14: Market trends
PART 15: Vendor landscape
PART 16: Key vendor analysis
- Abbott Diagnostics
- Danaher Corporation
- Roche Diagnostics
- Siemens Healthcare
- Sysmex
- Other prominent vendors
PART 17: Appendix
PART 18: Explore Technavio